share_log

Is It Time To Consider Buying Dolby Laboratories, Inc. (NYSE:DLB)?

Is It Time To Consider Buying Dolby Laboratories, Inc. (NYSE:DLB)?

现在是考虑购买杜比实验室有限公司(纽交所代码:DLB)的时候了吗?
Simply Wall St ·  2024/11/30 22:10

Dolby Laboratories, Inc. (NYSE:DLB), is not the largest company out there, but it saw a double-digit share price rise of over 10% in the past couple of months on the NYSE. The recent rally in share prices has nudged the company in the right direction, though it still falls short of its yearly peak. As a well-established company, which tends to be well-covered by analysts, you could assume any recent changes in the company's outlook is already priced into the stock. However, could the stock still be trading at a relatively cheap price? Let's take a look at Dolby Laboratories's outlook and value based on the most recent financial data to see if the opportunity still exists.

杜比实验室(NYSE:DLB)可能不是市值最高的公司,但在过去几个月里在纽约证券交易所股价上涨了超过10%。最近股价上涨推动了公司朝着正确的方向发展,尽管仍未达到年度峰值。作为一家经过充分分析的老牌公司,你可能会认为市场已经充分反映了公司展望的变化。然而,这支股票是否仍然以相对低廉的价格交易?让我们根据最近的财务数据来看一下杜比实验室的展望和价值,看看是否还存在机会。

What Is Dolby Laboratories Worth?

杜比实验室的价值是多少?

Good news, investors! Dolby Laboratories is still a bargain right now according to our price multiple model, which compares the company's price-to-earnings ratio to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. we find that Dolby Laboratories's ratio of 28.55x is below its peer average of 42.34x, which indicates the stock is trading at a lower price compared to the Software industry. What's more interesting is that, Dolby Laboratories's share price is quite stable, which could mean two things: firstly, it may take the share price a while to move closer to its industry peers, and secondly, there may be less chances to buy low in the future once it reaches that value. This is because the stock is less volatile than the wider market given its low beta.

投资者们有福了!根据我们的价格倍数模型,杜比实验室现在仍然是一个便宜的股票,我们将公司的市盈率与行业平均水平进行了比较。在这种情况下,我们使用了市盈率(PE)比率,因为没有足够的信息可靠地预测股票的现金流。我们发现,杜比实验室的市盈率为28.55倍,低于同行业的42.34倍,这表明该股票的价格相对于软件行业来说较低。更有趣的是,杜比实验室的股价非常稳定,这可能意味着两件事:首先,股价可能需要一段时间才能接近同行业水平,其次,一旦达到这个价值,未来买入时机可能会减少。这是因为相较于更广泛的市场,该股票的波动性较低。

What kind of growth will Dolby Laboratories generate?

杜比实验室将产生怎样的增长?

big
NYSE:DLB Earnings and Revenue Growth November 30th 2024
纽约证券交易所:DLB 收益和营业收入增长2024年11月30日

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. Dolby Laboratories' earnings over the next few years are expected to increase by 26%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

希望在投资组合中寻找增长的投资者可能会考虑在购买股票前评估公司的前景。以优惠的价格购买前景良好的优质公司总是一个不错的投资,所以让我们也来看看公司的未来预期。预计未来几年,杜比实验室的盈利将增长26%,表明前景非常乐观。这将导致更强劲的现金流,为更高的股票价值提供支持。

What This Means For You

这对你意味着什么

Are you a shareholder? Since DLB is currently below the industry PE ratio, it may be a great time to accumulate more of your holdings in the stock. With a positive outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as capital structure to consider, which could explain the current price multiple.

您是股东吗?由于杜比实验室当前低于行业市盈率,现在可能是增加您的股票持有量的好时机。展望未来看好的情况下,这种增长似乎还没有完全反映在股价中。然而,还有其他因素如资本结构需要考虑,这可能解释了目前的价格多重性。

Are you a potential investor? If you've been keeping an eye on DLB for a while, now might be the time to make a leap. Its prosperous future profit outlook isn't fully reflected in the current share price yet, which means it's not too late to buy DLB. But before you make any investment decisions, consider other factors such as the track record of its management team, in order to make a well-informed investment decision.

您是潜在投资者吗? 如果您一直关注着杜比实验室一段时间,现在可能是采取行动的时候。其繁荣的未来利润前景尚未完全反映在当前股价中,这意味着现在买入杜比实验室还不算太晚。但在做出任何投资决策之前,考虑其他因素如管理团队的业绩记录,以便做出明智的投资决策。

Keep in mind, when it comes to analysing a stock it's worth noting the risks involved. In terms of investment risks, we've identified 1 warning sign with Dolby Laboratories, and understanding it should be part of your investment process.

请记住,当分析股票时,值得注意涉及的风险。在投资风险方面,我们已经确定了一个与杜比实验室有关的警示信号,了解并遵循它应该是您的投资过程的一部分。

If you are no longer interested in Dolby Laboratories, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您对杜比实验室不感兴趣了,您可以使用我们的免费平台查看我们的超过50只其他具有高增长潜力的股票清单。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧吗?请直接与我们联系。或者,发送电子邮件至editorial-team @ simplywallst.com。
Simply Wall St的这篇文章是一般性质的。我们仅基于历史数据和分析师预测提供评论,使用公正的方法,我们的文章并非意在提供财务建议。这并不构成买入或卖出任何股票的建议,并且不考虑您的目标或财务状况。我们旨在为您带来基于基础数据驱动的长期聚焦分析。请注意,我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St对提及的任何股票都没有持仓。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发